Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen(196170) Changes CEO from Soon Jae Park to Tae Yeon Jeon

Posted on December 26, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen(196170) Changes CEO from Soon Jae Park to Tae Yeon Jeon

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-12-26

Disclosure Type: Change of CEO

💡 3-Second Summary

The CEO of Alteogen has been changed from Soon Jae Park to Tae Yeon Jeon. The new CEO is a former Vice President of the company with a background as a U.S. patent attorney.

📊 1. [Key Disclosure Content & Summary of Major Figures]

This disclosure is a mandatory regulatory filing announcing a change in the company’s chief executive officer (CEO) following a board of directors’ resolution.

  • Pre-change CEO: Soon Jae Park
  • Post-change CEO: Tae Yeon Jeon
  • Reason for Change: Appointment of a new CEO
  • Effective Date & Board Resolution Date: December 26, 2025 (2 out of 2 outside directors attended, auditor attended)
  • Profile and Shareholding of the New CEO:
    • Date of Birth: August 12, 1965
    • Shares Owned: 7,200 shares (0.01% ownership stake)
  • Key Career History of the New CEO:
    • Vice President at Alteogen Inc. (September 1, 2020 – Present)
    • U.S. Patent Attorney at DARA Strategic Technology Localization Center (October 16, 2017 – March 7, 2020)

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Personnel Change & Career Background: The CEO has been changed from Soon Jae Park to Tae Yeon Jeon. The newly appointed CEO, Tae Yeon Jeon, has served as Vice President at Alteogen since 2020 and has prior career experience working as a U.S. patent attorney.
  • Omitted Information in Disclosure: The specific background of this leadership change and the future role of the former CEO, Soon Jae Park, are not specified within this official disclosure.
  • Investor Interpretation: While the new CEO’s existing internal career history may serve as a reference point regarding operational continuity, any future strategic shifts must be verified through subsequent disclosures. Given the new CEO’s low equity ownership (0.01%), monitoring future shareholding dynamics is also recommended.

📝 Editor’s Comment (by K-STOCK Editor)

The CEO has been changed from Soon Jae Park to Tae Yeon Jeon. The newly appointed CEO, Tae Yeon Jeon, has served as Vice President at Alteogen since 2020 and has prior career experience working as a U.S. patent attorney. The specific background of this leadership change and the future role of the former CEO, Soon Jae Park, are not specified within this official disclosure. While the new CEO’s existing internal career history may serve as a reference point regarding operational continuity, any future strategic shifts must be verified through subsequent disclosures. This commentary outlines objective metrics and does not constitute any buy or sell signals.

📢 Disclaimer & Source Information

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] ISU PETASYS (007660) Warns Shareholders of New Dividend Rule—Dec 31 Holding Does Not Guarantee Payout
Next Post: [Disclosure] Hanmi Semiconductor (042700) Joins National ‘Value-Up’ Drive, Disclosing 90% HBM Market Monopoly and Aerospace Milestones in Corporate Value-Up Plan

Related Posts

[Disclosure] Alteogen(196170) Designated as Short Selling Overheated Stock… Short Selling Banned on Dec 8 Disclosures
[Disclosure] Alteogen (196170) Issued Advance Notice of Investment Warning Stock Designation; To Be Designated as Investment Caution Stock on Jan 6 Disclosures
[Disclosure] Alteogen (196170) Hits Jackpot: Signs KRW 867.5B Exclusive License Deal with Global Big Pharma Biogen for ALT-B4 Bio & Healthcare
[Disclosure] Alteogen (196170) Sets November 21 as Record Date to Determine Voting Rights for Extraordinary General Meeting Disclosures
[Disclosure] Alteogen (196170) Announces AGM Results; Re-election of CEO Park Soon-jae and Approval of All Proposed Agendas Disclosures
[Disclosure] Alteogen (196170) Clarifies Media Report on ‘KRW 200B RCPS Issuance and Shinhan Securities as Lead Manager’: “Under Consideration But Unconfirmed; No Lead Manager Contract Signed” Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme